STOCK TITAN

Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Biotricity Inc. (NASDAQ:BTCY) announced a conference call on November 14, 2022, at 4:30 p.m. ET to discuss its fiscal 2023 second quarter financial results and provide a business update. The call is accessible via a toll-free number and a webcast link. A replay will be available until November 28, 2022.

Biotricity specializes in remote health monitoring solutions for chronic care management, aiming to fill gaps in preventive health care.

Positive
  • The upcoming conference call will provide insights on financial results, potentially offering investors a clearer outlook.
  • Biotricity is focused on bridging gaps in remote monitoring, indicating a commitment to innovation in healthcare technology.
Negative
  • None.

REDWOOD CITY, CA / ACCESSWIRE / November 1, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call on Monday, November 14, 2022 at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 second quarter and provide a business update.

Financial Results Conference Call
Additional details are available under the Investor Relations section of the Company's website: https://www.biotricity.com/investors/

Event:

Biotricity Fiscal 2023 Second Quarter Financial Results Conference Call

Date:

Monday, November 14, 2022

Time:

4:30 p.m. Eastern Time

Live Call:

1-866-575-6539 (U.S. Toll-Free) or 1-646-828-8193 (International)

Webcast:

https://viavid.webcasts.com/starthere.jsp?ei=1579691&tp_key=ec8c6fdf26

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until November 28, 2022 and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 8592059.

About Biotricity:
Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity's unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com.

Contacts:
Investor Relations:
KCSA Strategic Communications
Valter Pinto or Jack Perkins
(212) 896-1254
investors@biotricity.com

SOURCE: Biotricity, Inc.



View source version on accesswire.com:
https://www.accesswire.com/723230/Biotricity-to-Host-Fiscal-2023-Second-Quarter-Financial-Results-on-November-14th-at-430-PM-ET

FAQ

When is Biotricity's financial results conference call?

Biotricity's financial results conference call is scheduled for November 14, 2022, at 4:30 p.m. ET.

How can I listen to Biotricity's conference call?

You can listen to Biotricity's conference call by calling 1-866-575-6539 (U.S. Toll-Free) or 1-646-828-8193 (International), and also via webcast.

Will there be a replay of the call?

Yes, a replay of the call will be available until November 28, 2022, by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International).

What is the purpose of the conference call?

The conference call aims to discuss Biotricity's fiscal 2023 second quarter financial results and provide a business update.

What does Biotricity specialize in?

Biotricity specializes in remote health monitoring solutions for chronic care management and preventive health care.

BIOTRICITY INC

OTC:BTCY

BTCY Rankings

BTCY Latest News

BTCY Stock Data

14.29M
14.43M
40.89%
2.11%
2.07%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
REDWOOD CITY